SlateStone Wealth LLC Has $2.76 Million Holdings in Zoetis Inc (NYSE:ZTS)

SlateStone Wealth LLC raised its holdings in Zoetis Inc (NYSE:ZTS) by 3.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,849 shares of the company’s stock after buying an additional 638 shares during the quarter. SlateStone Wealth LLC’s holdings in Zoetis were worth $2,759,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. State Street Corp increased its holdings in shares of Zoetis by 1.4% during the fourth quarter. State Street Corp now owns 19,883,222 shares of the company’s stock valued at $2,631,544,000 after acquiring an additional 283,233 shares in the last quarter. Polen Capital Management LLC increased its holdings in shares of Zoetis by 2.8% during the fourth quarter. Polen Capital Management LLC now owns 10,826,159 shares of the company’s stock valued at $1,432,842,000 after acquiring an additional 293,598 shares in the last quarter. California Public Employees Retirement System increased its holdings in shares of Zoetis by 12.0% during the third quarter. California Public Employees Retirement System now owns 2,397,369 shares of the company’s stock valued at $298,688,000 after acquiring an additional 256,715 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Zoetis by 8.0% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,979,391 shares of the company’s stock valued at $246,612,000 after acquiring an additional 147,442 shares in the last quarter. Finally, Banque Pictet & Cie SA increased its holdings in shares of Zoetis by 1.1% during the fourth quarter. Banque Pictet & Cie SA now owns 1,791,619 shares of the company’s stock valued at $237,121,000 after acquiring an additional 19,820 shares in the last quarter. 90.04% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have recently commented on ZTS shares. Cfra upgraded Zoetis from a “buy” rating to a “strong-buy” rating and boosted their price objective for the company from $147.00 to $160.00 in a report on Thursday. SunTrust Banks restated a “hold” rating and set a $145.00 price objective on shares of Zoetis in a report on Friday. Bank of America restated a “hold” rating and set a $145.00 price objective on shares of Zoetis in a report on Wednesday. Morgan Stanley boosted their price objective on Zoetis from $136.00 to $148.00 and gave the company an “equal weight” rating in a report on Friday. Finally, Zacks Investment Research upgraded Zoetis from a “hold” rating to a “buy” rating and set a $142.00 price objective for the company in a report on Thursday, December 26th. Eight equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $135.53.

Zoetis stock traded down $0.77 during trading on Friday, hitting $144.17. 1,810,544 shares of the company were exchanged, compared to its average volume of 2,018,624. The business’s 50 day moving average is $136.94 and its 200 day moving average is $127.01. Zoetis Inc has a 52 week low of $91.21 and a 52 week high of $146.26. The company has a market capitalization of $67.90 billion, a P/E ratio of 47.58, a PEG ratio of 3.10 and a beta of 0.81. The company has a current ratio of 4.39, a quick ratio of 3.02 and a debt-to-equity ratio of 2.47.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.88 by $0.04. Zoetis had a return on equity of 70.78% and a net margin of 23.76%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. Zoetis’s revenue was up 7.0% compared to the same quarter last year. Equities analysts expect that Zoetis Inc will post 3.6 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, April 17th will be issued a dividend of $0.20 per share. The ex-dividend date is Thursday, April 16th. This represents a $0.80 annualized dividend and a yield of 0.55%. Zoetis’s dividend payout ratio (DPR) is currently 25.56%.

In related news, EVP Roxanne Lagano sold 4,463 shares of the company’s stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $118.99, for a total transaction of $531,052.37. Following the completion of the sale, the executive vice president now owns 33,190 shares in the company, valued at $3,949,278.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Andrew Fenton sold 12,705 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $120.30, for a total value of $1,528,411.50. Following the sale, the executive vice president now owns 21,530 shares of the company’s stock, valued at approximately $2,590,059. The disclosure for this sale can be found here. Insiders have sold 125,001 shares of company stock valued at $15,342,770 in the last quarter. 0.29% of the stock is currently owned by corporate insiders.

About Zoetis

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Read More: Guidelines for Successful Channel Trading

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.